Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction.

Kurtz DM, Esfahani MS, Scherer F, Soo J, Jin MC, Liu CL, Newman AM, Dührsen U, Hüttmann A, Casasnovas O, Westin JR, Ritgen M, Böttcher S, Langerak AW, Roschewski M, Wilson WH, Gaidano G, Rossi D, Bahlo J, Hallek M, Tibshirani R, Diehn M, Alizadeh AA.

Cell. 2019 Jul 25;178(3):699-713.e19. doi: 10.1016/j.cell.2019.06.011. Epub 2019 Jul 4.

PMID:
31280963
2.

Determining cell type abundance and expression from bulk tissues with digital cytometry.

Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, Khodadoust MS, Esfahani MS, Luca BA, Steiner D, Diehn M, Alizadeh AA.

Nat Biotechnol. 2019 Jul;37(7):773-782. doi: 10.1038/s41587-019-0114-2. Epub 2019 May 6.

PMID:
31061481
3.

Reply to J. Wang et al.

Kurtz DM, Scherer F, Jin MC, Soo J, Craig AFM, Esfahani MS, Chabon JJ, Stehr H, Liu CL, Tibshirani R, Maeda LS, Gupta NK, Khodadoust MS, Advani RH, Newman AM, Dührsen U, Hüttmann A, Meignan M, Casasnovas O, Westin JR, Roschewski M, Wilson WH, Gaidano G, Rossi D, Diehn M, Alizadeh AA.

J Clin Oncol. 2019 Mar 20;37(9):755-757. doi: 10.1200/JCO.18.01907. Epub 2019 Feb 12. No abstract available.

PMID:
30753108
4.

ICU physicians' and internists' survival predictions for patients evaluated for admission to the intensive care unit.

Escher M, Ricou B, Nendaz M, Scherer F, Cullati S, Hudelson P, Perneger T.

Ann Intensive Care. 2018 Nov 14;8(1):108. doi: 10.1186/s13613-018-0456-9.

5.

Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma.

Kurtz DM, Scherer F, Jin MC, Soo J, Craig AFM, Esfahani MS, Chabon JJ, Stehr H, Liu CL, Tibshirani R, Maeda LS, Gupta NK, Khodadoust MS, Advani RH, Levy R, Newman AM, Dührsen U, Hüttmann A, Meignan M, Casasnovas RO, Westin JR, Roschewski M, Wilson WH, Gaidano G, Rossi D, Diehn M, Alizadeh AA.

J Clin Oncol. 2018 Oct 1;36(28):2845-2853. doi: 10.1200/JCO.2018.78.5246. Epub 2018 Aug 20.

PMID:
30125215
6.

Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.

Chaudhuri AA, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, Khodadoust MS, Esfahani MS, Liu CL, Zhou L, Scherer F, Kurtz DM, Say C, Carter JN, Merriott DJ, Dudley JC, Binkley MS, Modlin L, Padda SK, Gensheimer MF, West RB, Shrager JB, Neal JW, Wakelee HA, Loo BW Jr, Alizadeh AA, Diehn M.

Cancer Discov. 2017 Dec;7(12):1394-1403. doi: 10.1158/2159-8290.CD-17-0716. Epub 2017 Sep 24.

7.

Are role perceptions of residents and nurses translated into action?

Bochatay N, Muller-Juge V, Scherer F, Cottin G, Cullati S, Blondon KS, Hudelson P, Maître F, Vu NV, Savoldelli GL, Nendaz MR.

BMC Med Educ. 2017 Aug 18;17(1):138. doi: 10.1186/s12909-017-0976-2.

8.

High-throughput sequencing for noninvasive disease detection in hematologic malignancies.

Scherer F, Kurtz DM, Diehn M, Alizadeh AA.

Blood. 2017 Jul 27;130(4):440-452. doi: 10.1182/blood-2017-03-735639. Epub 2017 Jun 9. Review.

9.

Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.

Chabon JJ, Simmons AD, Lovejoy AF, Esfahani MS, Newman AM, Haringsma HJ, Kurtz DM, Stehr H, Scherer F, Karlovich CA, Harding TC, Durkin KA, Otterson GA, Thomas Purcell W, Ross Camidge D, Goldman JW, Sequist LV, Piotrowska Z, Wakelee HA, Neal JW, Alizadeh AA, Diehn M.

Nat Commun. 2016 Nov 14;7:13513. doi: 10.1038/ncomms13513. No abstract available.

10.

Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.

Scherer F, Kurtz DM, Newman AM, Stehr H, Craig AF, Esfahani MS, Lovejoy AF, Chabon JJ, Klass DM, Liu CL, Zhou L, Glover C, Visser BC, Poultsides GA, Advani RH, Maeda LS, Gupta NK, Levy R, Ohgami RS, Kunder CA, Diehn M, Alizadeh AA.

Sci Transl Med. 2016 Nov 9;8(364):364ra155.

11.

Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.

Chabon JJ, Simmons AD, Lovejoy AF, Esfahani MS, Newman AM, Haringsma HJ, Kurtz DM, Stehr H, Scherer F, Karlovich CA, Harding TC, Durkin KA, Otterson GA, Purcell WT, Camidge DR, Goldman JW, Sequist LV, Piotrowska Z, Wakelee HA, Neal JW, Alizadeh AA, Diehn M.

Nat Commun. 2016 Jun 10;7:11815. doi: 10.1038/ncomms11815. Erratum in: Nat Commun. 2016 Nov 14;7:13513.

12.

Integrated digital error suppression for improved detection of circulating tumor DNA.

Newman AM, Lovejoy AF, Klass DM, Kurtz DM, Chabon JJ, Scherer F, Stehr H, Liu CL, Bratman SV, Say C, Zhou L, Carter JN, West RB, Sledge GW, Shrager JB, Loo BW Jr, Neal JW, Wakelee HA, Diehn M, Alizadeh AA.

Nat Biotechnol. 2016 May;34(5):547-555. doi: 10.1038/nbt.3520. Epub 2016 Mar 28.

13.

Selection patterns of B-cell receptors and the natural history of follicular lymphoma.

Scherer F, van der Burgt M, Kiełbasa SM, Bertinetti-Lapatki C, Dühren von Minden M, Mikesch K, Zirlik K, de Wreede L, Veelken H, Navarrete MA.

Br J Haematol. 2016 Dec;175(5):972-975. doi: 10.1111/bjh.13901. Epub 2015 Dec 21. No abstract available.

PMID:
26687432
14.

Corrigendum: Organocatalytic removal of formaldehyde adducts from RNA and DNA bases.

Karmakar S, Harcourt EM, Hewings DS, Scherer F, Lovejoy AF, Kurtz DM, Ehrenschwender T, Barandun LJ, Roost C, Alizadeh AA, Kool ET.

Nat Chem. 2015 Dec;7(12):1033. doi: 10.1038/nchem.2401. No abstract available.

PMID:
26587722
15.

Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia.

Duque-Afonso J, Feng J, Scherer F, Lin CH, Wong SH, Wang Z, Iwasaki M, Cleary ML.

J Clin Invest. 2015 Sep;125(9):3667-80. doi: 10.1172/JCI81158. Epub 2015 Aug 24.

16.

Organocatalytic removal of formaldehyde adducts from RNA and DNA bases.

Karmakar S, Harcourt EM, Hewings DS, Scherer F, Lovejoy AF, Kurtz DM, Ehrenschwender T, Barandun LJ, Roost C, Alizadeh AA, Kool ET.

Nat Chem. 2015 Sep;7(9):752-8. doi: 10.1038/nchem.2307. Epub 2015 Aug 3. Erratum in: Nat Chem. 2015 Dec;7(12):1033.

17.

Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.

Kurtz DM, Green MR, Bratman SV, Scherer F, Liu CL, Kunder CA, Takahashi K, Glover C, Keane C, Kihira S, Visser B, Callahan J, Kong KA, Faham M, Corbelli KS, Miklos D, Advani RH, Levy R, Hicks RJ, Hertzberg M, Ohgami RS, Gandhi MK, Diehn M, Alizadeh AA.

Blood. 2015 Jun 11;125(24):3679-87. doi: 10.1182/blood-2015-03-635169. Epub 2015 Apr 17.

18.

Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation.

Scherer F, Navarrete MA, Bertinetti-Lapatki C, Boehm J, Schmitt-Graeff A, Veelken H.

Leuk Lymphoma. 2016;57(1):151-60. doi: 10.3109/10428194.2015.1037758. Epub 2015 May 18.

PMID:
25860234
19.

Lesser time of preoperative fasting and early postoperative feeding are safe?

Ludwig RB, Paludo J, Fernandes D, Scherer F.

Arq Bras Cir Dig. 2013 Jan-Mar;26(1):54-8. Review. English, Portuguese.

20.

Mergers and innovation in the pharmaceutical industry.

Comanor WS, Scherer FM.

J Health Econ. 2013 Jan;32(1):106-13. doi: 10.1016/j.jhealeco.2012.09.006. Epub 2012 Sep 29.

PMID:
23220457
21.

Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation.

Bordon V, Gennery AR, Slatter MA, Vandecruys E, Laureys G, Veys P, Qasim W, Friedrich W, Wulfraat NM, Scherer F, Cant AJ, Fischer A, Cavazzana-Calvo M, Bredius RG, Notarangelo LD, Mazzolari E, Neven B, Güngör T; Inborn Error Working Party of the European Bone Marrow Transplantation (EBMT) group.

Blood. 2010 Jul 8;116(1):27-35. doi: 10.1182/blood-2010-01-259168. Epub 2010 Apr 7. Erratum in: Blood. 2010 Sep 30;116(13):2402. Waseem, Qasim [corrected to Qasim, Waseem];Tayfun, Güngör [corrected to Güngör, Tayfun]. Blood. 2011 Feb 10;117(6):2077. Cavazanna-Calvo, Marina [corrected to Cavazzana-Calvo, Marina].

22.

Price controls and global pharmaceutical progress.

Scherer FM.

Health Aff (Millwood). 2009 Jan-Feb;28(1):w161-4. doi: 10.1377/hlthaff.28.1.w161. Epub 2008 Dec 16.

PMID:
19088103
23.

First successful bone marrow transplantation for X-linked chronic granulomatous disease by using preimplantation female gender typing and HLA matching.

Reichenbach J, Van de Velde H, De Rycke M, Staessen C, Platteau P, Baetens P, Güngör T, Ozsahin H, Scherer F, Siler U, Seger RA, Liebaers I.

Pediatrics. 2008 Sep;122(3):e778-82. doi: 10.1542/peds.2008-0123.

PMID:
18762514
24.

Correlation between recent thymic emigrants and CD31+ (PECAM-1) CD4+ T cells in normal individuals during aging and in lymphopenic children.

Junge S, Kloeckener-Gruissem B, Zufferey R, Keisker A, Salgo B, Fauchere JC, Scherer F, Shalaby T, Grotzer M, Siler U, Seger R, Güngör T.

Eur J Immunol. 2007 Nov;37(11):3270-80.

25.

Psychological distress in primary care patients with heart failure: a longitudinal study.

Scherer M, Himmel W, Stanske B, Scherer F, Koschack J, Kochen MM, Herrmann-Lingen C.

Br J Gen Pract. 2007 Oct;57(543):801-7.

26.

Favorable response of pediatric stem cell recipients to human protein C concentrate substitution for veno-occlusive disease.

Eber SW, Gungor T, Veldman A, Sykora K, Scherer F, Fischer D, Grigull L.

Pediatr Transplant. 2007 Feb;11(1):49-57.

PMID:
17239123
27.

Satisfaction of patients hospitalised in psychiatric hospitals: a randomised comparison of two psychiatric-specific and one generic satisfaction questionnaires.

Peytremann-Bridevaux I, Scherer F, Peer L, Cathieni F, Bonsack C, Cléopas A, Kolly V, Perneger TV, Burnand B.

BMC Health Serv Res. 2006 Aug 28;6:108.

28.
29.

The pharmaceutical industry--prices and progress.

Scherer FM.

N Engl J Med. 2004 Aug 26;351(9):927-32. No abstract available.

PMID:
15329432
30.

Use of the World Wide Web to implement clinical practice guidelines: a feasibility study.

Jeannot JG, Scherer F, Pittet V, Burnand B, Vader JP.

J Med Internet Res. 2003 Apr-Jun;5(2):e12.

31.

The magnetofection method: using magnetic force to enhance gene delivery.

Plank C, Schillinger U, Scherer F, Bergemann C, Rémy JS, Krötz F, Anton M, Lausier J, Rosenecker J.

Biol Chem. 2003 May;384(5):737-47. Review.

PMID:
12817470
32.

Magnetofection: enhancing and targeting gene delivery with superparamagnetic nanoparticles and magnetic fields.

Plank C, Scherer F, Schillinger U, Bergemann C, Anton M.

J Liposome Res. 2003 Feb;13(1):29-32. Review. No abstract available.

PMID:
12725725
33.

The economics of human gene patents.

Scherer FM.

Acad Med. 2002 Dec;77(12 Pt 2):1348-67. Review.

PMID:
12480645
34.

Nonviral vector loaded collagen sponges for sustained gene delivery in vitro and in vivo.

Scherer F, Schillinger U, Putz U, Stemberger A, Plank C.

J Gene Med. 2002 Nov-Dec;4(6):634-43.

PMID:
12439855
35.

Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo.

Scherer F, Anton M, Schillinger U, Henke J, Bergemann C, Krüger A, Gänsbacher B, Plank C.

Gene Ther. 2002 Jan;9(2):102-9.

36.

Pharmacokinetics of native Escherichia coli asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL-BFM 95 reinduction treatment.

Müller HJ, Beier R, Löning L, Blütters-Sawatzki R, Dörffel W, Maass E, Müller-Weihrich S, Scheel-Walter HG, Scherer F, Stahnke K, Schrappe M, Horn A, Lümkemann K, Boos J.

Br J Haematol. 2001 Sep;114(4):794-9.

PMID:
11564065
37.

The link between gross profitability and pharmaceutical R&D spending.

Scherer FM.

Health Aff (Millwood). 2001 Sep-Oct;20(5):216-20. No abstract available.

PMID:
11558706
38.

Cerec on the threshold to "generally accepted medical practice".

Scherer F.

Int J Comput Dent. 2000 Jan;3(1):5-6. English, German. No abstract available.

PMID:
11351386
39.

LPS directly induces oxygen radical production in human monocytes via LPS binding protein and CD14.

Landmann R, Scherer F, Schumann R, Link S, Sansano S, Zimmerli W.

J Leukoc Biol. 1995 Mar;57(3):440-9.

PMID:
7533819
40.

Post-patent barriers to entry in the pharmaceutical industry.

Scherer FM.

J Health Econ. 1985 Mar;4(1):83-7. No abstract available.

PMID:
10271148
41.

A nurse's reflection Johns Hopkins Hospital 1942-1944.

Scherer FS.

Alumni Mag. 1985 Jan;85(1):13-7. No abstract available.

PMID:
3884021
42.

Dental hygiene quality assurance: definitions, issues, and directions for Canada.

Pimlott JF, Chambers LW, Feller SJ, Scherer FK.

Can Dent Hyg. 1985 Spring;19(1):20-3. No abstract available.

PMID:
3857955
43.

[Determination of selected quality criteria for rabbit meat].

Scharner E, Schiefer G, Scherer F.

Nahrung. 1974;18(1):47-51. German. No abstract available.

PMID:
4858834
45.

[Perforated duodenal diverticulum and heal of pancreas carcinoma].

Scherer F.

Chirurg. 1968 Oct;39(10):461-4. German. No abstract available.

PMID:
4973846
46.

[Clinical picture of small intestine myoneuromas].

Scherer F.

Langenbecks Arch Chir. 1968;322:114-6. German. No abstract available.

PMID:
5758702
47.

[Studies on simultaneous tetanus vaccination].

Kingreen R, Scherer F.

Chirurg. 1967 Aug;38(8):366-9. German. No abstract available.

PMID:
5593472
48.

[CLINICAL EXPERIENCES WITH A NEW PLASMA EXPANDER].

SCHERER F, WUNSCH KH.

Chirurg. 1963 Aug;34:356-61. German. No abstract available.

PMID:
14045362
49.

[Tetanus simultaneous vaccination; an experimental study].

SCHERER F, DICKGIESSER F, ALBRECHT KF.

Chirurg. 1959 Jun;30(6):251-60. German. No abstract available.

PMID:
13671695
50.

[Study methods in organic blood circulation disorders; a critical survey for hospital and practice. II].

SCHERER F.

Dtsch Med Wochenschr. 1958 Nov 21;83(47):2093-8. German. No abstract available.

PMID:
13609337

Supplemental Content

Loading ...
Support Center